Category Innovation/ R&D

IPRs Seen To Impact Climate Change Technology Transfer In Africa

NAIROBI, Kenya -- With high vulnerability to adverse effects of climate change, African countries are keen to develop, acquire and disseminate technologies for mitigation and adaptation.

Fairness In Research Partnerships, Reporting System Presented At Geneva Health Forum

Research collaborations between institutions in the North and institutions in the South often show a scientific and power imbalance. In the context of growing concerns about this issue, initiatives are being developed to increase fairness in research partnerships. In particular, the Research Fairness Initiative, providing a reporting system for institutions is gaining traction, according to speakers at the Geneva Health Forum this week.

US Imprisons Chinese Scientist For Theft Of Engineered Rice Seeds

A Chinese scientist has been sentenced to jail for more than 10 years for conspiring to steal samples of a highly developed variety of genetically modified rice seeds from a Kansas biopharmaceutical research facility, the US Justice Department said in a release.

Irrepressible Rise Of China In International Patent Applications, Developing Countries Lagging

If the United States remains the champion of international patent applications at the World Intellectual Property Organization, China is now on its heels, and knocked Japan off the second place in 2017, according to numbers provided by WIPO. Southeast Asia is now a strong source of international applications, while developing countries still stand as a poor relation of the intellectual property system, though some of them are progressing steadily.

UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India

The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments.

Key Drug Innovations Often Don’t See Market Rewards, Academic Says

There is little evidence that more innovative or therapeutically valuable pharmaceutical products are rewarded, or that patents are the best way to do so, Economics Professor Margaret Kyle of the Centre d’économie industrielle of Mines ParisTech says in an upcoming study for the Review of Industrial Organization.

UN Member States Briefed On Innovation And Access To Health Technologies

NEW YORK -- A major event on innovation and access to health technologies took place at the United Nations in New York last week, in which UN member states were briefed on ideas and efforts to promote these issues at the forefront of global health policy.

Sir John Sulston, Human Genome Project Leader, Remembered For Words On IP And Health R&D

Nobel Prize winner Sir John Sulston passed away on 6 March at the age of 75, and was widely remembered in the press and scientific circles, celebrating his research, his wisdom, and his leadership of the landmark Human Genome Project. Intellectual Property Watch recalls his visionary warning and advice a decade ago about the intellectual property system, investment, and science that is still valuable today.

Introduction Of A Grace Period In Europe

The protection of inventions is a cornerstone to encourage innovation as engine of economic growth. As one of the world‘s leading centres for innovation, the level of scientific and technological performance in Germany is very high, thanks to an excellent research landscape and a good technological and economic basis. But the global innovation competition is intensifying, and new competitors are seeking to enter international markets. However, Germany is falling short of its potential when it comes to leveraging technology to create new products, writes Michael Kahnert.